In the present study, we examined the transcriptome, DNMT3A genotype and IL-10 proteome of whole peripheral blood to differentiate immune response pathways associated with RB versus PB outcomes in clinical MRSA bacteremia. The gene discussed is IL10; the disease is bacterial infectious disease with sepsis.